Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Ilaris NIS in Korea |
Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) | South Korea | NCT06838143 | |
Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia |
Hidradenitis Suppurativa (HS) | Saudi Arabia | NCT06785779 | |
Fabhalta Capsules Specified Drug-use Survey |
C3 Glomerulopathy | Japan | NCT07156149 | |
Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters. |
Breast Cancer | United Kingdom | NCT07243002 | |
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) |
Primary Hypercholesterolemia or Mixed Dyslipidemia | South Korea | NCT06770543 | |
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer | Phase1, Phase2 | Japan Singapore Taiwan United States View all |
NCT07288359 |
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults |
Cryptosporidiosis | Phase2 | United States | NCT07249463 |
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis |
Secondary Progressive Multiple Sclerosis (SPMS) | Phase3 | Argentina Australia Bulgaria Canada China Colombia Czechia France Germany Hungary India Israel Italy Portugal Romania South Africa Spain Switzerland United Kingdom United States View all |
NCT07225504 |
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia |
Breast Cancer | Russia | NCT06930859 | |
A Study of DII235 in Adults With Elevated Lipoprotein(a) |
Lipoprotein Disorder | Phase2 | China Germany Japan United States View all |
NCT07235046 |